Sponsors, CROs and academic research teams choosing an eCOA platform for a regulated clinical trial.
Scope Electronic clinical outcome assessment (eCOA) platforms that capture patient-reported (ePRO), clinician-reported, observer-reported and performance outcomes in regulated clinical trials, as a sponsor, CRO or academic research team would shortlist them.
These notes describe the products in the eCOA guide.
Kayentis
Best for
Phase II-III sponsors that want a specialist eCOA vendor with site and patient helpdesk support
What to consider
Kayentis is an eCOA specialist with 280+ trials in 85 countries and 120 languages, and its Clin'form app runs on BYOD, provisioned devices, web and interview mode. It does not publish build timelines, approval counts or prices.
Sponsors that want eCOA, IRT and eConsent from one vendor across many languages
What to consider
YPrime covers 250+ languages and 100+ countries and integrates eCOA with its own IRT and eConsent. It documents Part 11 and GxP compliance and nearly 1,000 studies, but no approval counts, and its ISO 27001 certification is still in progress. Builds are vendor-led and prices are not published.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Kayentis vs YPrime (eCOA): category feature evidence and sources. Products are not ranked.
Category feature
Kayentis
YPrime
Validated instrument library and licensingFeature definitions
Supported
A library of outcome-assessment instruments is documented.
Extended support
A validated or instrument-author-approved library plus managed instrument licensing are documented.
Kayentis
Extended support
Questionnaire library and translation tools built with linguistic validation agencies; licensing and validation handled with language-service partners.